Navigation Links
Medco Tops Fortune's Lists of 'World's Most Admired' Companies for Third Consecutive Year
Date:3/8/2010

FRANKLIN LAKES, N.J., March 8 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc. (NYSE: MHS), captured the No. 1 position within the Health Care: Pharmacy and Other Services sector on Fortune's World's Most Admired Companies List for the third consecutive year.  Medco ranked highest in five categories within that sector: innovation, use of corporate assets, quality of management, financial soundness, and quality of products/services.

According to the Fortune survey, Medco also received the following additional honors: No. 2 in the "Health Care: Pharmacy and Other Services" category for people management, long term investment and global competitiveness; and among the most admired companies in New Jersey.

Fortune, in partnership with the Hay Group, surveyed more than 667 companies across 55 industry sectors worldwide. To establish the rankings, executives, directors, and securities analysts were asked to rate companies in their own industry on nine criteria, from investment value to social responsibility. Results are featured in the March 22 issue of Fortune magazine.

"We are honored to be ranked the highest of our industry peers," said Medco Chairman and CEO David B. Snow, Jr. "That ranking validates our commitment to leveraging the power of advanced pharmacy to provide clinical excellence for our members and drive down total healthcare costs for our valued clients."

About Medco

Medco Health Solutions, Inc. (NYSE: MHS) is pioneering the world's most advanced pharmacy® and its clinical research and innovations are part of Medco making medicine smarter™ for approximately 65 million members.

With more than 20,000 employees dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2009 revenue of nearly $60 billion, Medco ranks 45th on the Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies.

For more information, go to http://www.medcohealth.com.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.

SOURCE Medco Health Solutions, Inc.

Back to top

RELATED LINKS
http://www.medcohealth.com

'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Medco Acquires Leading Genetics Healthcare Company, DNA Direct
2. Great Customer Service Just Got Better as Emedco Announces the Launch of their Completely Updated and Enhanced Website
3. N2Care Unveils Backyard Smart MEDcottage
4. Medco Health Solutions, United Drug Announce U.K. Homecare Pharmacy Joint Venture Serving Patients with Chronic and Complex Health Conditions; Innovations to Improve Clinical Quality, Reduce Costs
5. Gold Standard/Elsevier Launches MedCounselor Consumer Drug Information Modules
6. Medco Announces Date for Second-Quarter 2009 Financial Results
7. PATHFAST(R) Rapid Whole Blood Immunoassay Analyzer from Polymedco
8. Medcos Advanced Pharmacy Adds 162 New Jobs for Total of 1,400
9. Medco to Present at June 2009 Investor Conferences
10. Medco CEO to Present at the Sanford C. Bernstein & Co. LLC 25th Annual Strategic Decision Conference 2009
11. Medco to Present at the Deutsche Bank 34th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... owners, developers and operators of commercial real estate proudly announced that its service-based ... Health initiative. Team members portfolio-wide will continue Olshan Properties’ annual philanthropic tradition ...
(Date:5/4/2016)... ... 04, 2016 , ... Nike Rugby Camp's success is due in large part ... of Elite Rugby Camps and current Nike Camp director, has offered an all abilities ... , “I’m excited for our eighth summer here in San Diego,” says Willis. "We ...
(Date:5/4/2016)... NC (PRWEB) , ... May 04, 2016 , ... A ... in the world. The Duke Clinical Research Institute (DCRI) and analytics leader SAS will ... cardiovascular patient data collected by the Duke University Health System. , The DCRI ...
(Date:5/4/2016)... ... May 04, 2016 , ... All-Star Insurance of ... assist the people of their local community. The agency pledges to select a ... Their hope is to bring awareness to important local causes with fundraising and ...
(Date:5/4/2016)... ... May 04, 2016 , ... May kicked off with Melanoma ... United States. Dermatologist Dr. Ellen Turner is encouraging her patients, as well as residents ... on skin safety and health now and in the future. , The dermatology-specific awareness ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... -- According to market research "Global Magnetic ... Demand Forecast to 2022 - Industry Insights by Architecture ... High Field, Low to Mid Field, and Ultra High ... Vascular, Breast, Pelvic and Abdomen, Cardiac, and Other)" P&S ... was valued at $5,351.7 million in 2015, and it ...
(Date:5/3/2016)... , May 3, 2016 ... heute bekannt, dass sie einen entscheidenden Meilenstein ... haben: Ein Aufruf zum Handeln, um Patientenresultate ... Veröffentlichung trägt zu Fortschritten im Verständnis der ... hervor, ein Bewusstsein für Hepatische Enzephalopathie in ...
(Date:5/2/2016)... LAWRENCEVILLE, N.J. , May 2, 2016 /PRNewswire/ ... drug development company, today announced data from the ... dose escalating clinical trial (the OVATION Study) combining ... of care for the treatment of newly-diagnosed patients ... chemotherapy followed by interval debulking surgery.  In the ...
Breaking Medicine Technology: